Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma

The role of Mycoplasma pneumoniae (Mp) in the initiation and persistence of asthma remains elusive. Mp community-acquired respiratory distress syndrome toxin (CARDS Tx) is a unique virulence factor that induces an intense lymphocytic response and exacerbates asthma in animal models. We sought to det...

Full description

Saved in:
Bibliographic Details
Published inChest Vol. 140; no. 2; p. 401
Main Authors Peters, Jay, Singh, Harjinder, Brooks, Edward G, Diaz, Joseph, Kannan, Thirumalai R, Coalson, Jacqueline J, Baseman, Janet G, Cagle, Marianna, Baseman, Joel B
Format Journal Article
LanguageEnglish
Published United States 01.08.2011
Subjects
Online AccessGet more information

Cover

Loading…
Abstract The role of Mycoplasma pneumoniae (Mp) in the initiation and persistence of asthma remains elusive. Mp community-acquired respiratory distress syndrome toxin (CARDS Tx) is a unique virulence factor that induces an intense lymphocytic response and exacerbates asthma in animal models. We sought to determine the incidence of Mp infection and the presence of CARDS Tx in subjects with refractory asthma (RA). We conducted a prospective observational study in 64 subjects with RA. Respiratory secretions (sputum, nasal lavage, and throat swab) and blood were analyzed for the presence of CARDS Tx and P1 adhesin (P1) DNA by polymerase chain reaction (PCR), and CARDS Tx by antigen capture. Serum IgM and IgG antibodies to CARDS Tx were determined by enzyme-linked immunosorbent assay (ELISA). Thirty-three of 64 subjects (52%) tested positive for Mp: 29 of 33 by CARDS Tx vs 10 of 33 by P1 assays. Ten subjects followed longitudinally for up to 633 days tested persistently positive for Mp. There were no significant differences in Mp-specific IgG responses between Mp-positive and Mp-negative groups. Eight of 10 subjects who tested persistently positive failed to mount a substantial IgG response to CARDS Tx, and up to 8 weeks of clarithromycin failed to eradicate Mp in five subjects. Subjects with RA may be chronically infected with Mp. PCR for CARDS Tx appears to be the most sensitive method of identifying Mp infection. Despite the persistence of Mp in subjects with RA, some subjects failed to mount an IgG response, and macrolide therapy was insufficient to eradicate Mp.
AbstractList The role of Mycoplasma pneumoniae (Mp) in the initiation and persistence of asthma remains elusive. Mp community-acquired respiratory distress syndrome toxin (CARDS Tx) is a unique virulence factor that induces an intense lymphocytic response and exacerbates asthma in animal models. We sought to determine the incidence of Mp infection and the presence of CARDS Tx in subjects with refractory asthma (RA). We conducted a prospective observational study in 64 subjects with RA. Respiratory secretions (sputum, nasal lavage, and throat swab) and blood were analyzed for the presence of CARDS Tx and P1 adhesin (P1) DNA by polymerase chain reaction (PCR), and CARDS Tx by antigen capture. Serum IgM and IgG antibodies to CARDS Tx were determined by enzyme-linked immunosorbent assay (ELISA). Thirty-three of 64 subjects (52%) tested positive for Mp: 29 of 33 by CARDS Tx vs 10 of 33 by P1 assays. Ten subjects followed longitudinally for up to 633 days tested persistently positive for Mp. There were no significant differences in Mp-specific IgG responses between Mp-positive and Mp-negative groups. Eight of 10 subjects who tested persistently positive failed to mount a substantial IgG response to CARDS Tx, and up to 8 weeks of clarithromycin failed to eradicate Mp in five subjects. Subjects with RA may be chronically infected with Mp. PCR for CARDS Tx appears to be the most sensitive method of identifying Mp infection. Despite the persistence of Mp in subjects with RA, some subjects failed to mount an IgG response, and macrolide therapy was insufficient to eradicate Mp.
Author Diaz, Joseph
Kannan, Thirumalai R
Singh, Harjinder
Coalson, Jacqueline J
Baseman, Janet G
Cagle, Marianna
Baseman, Joel B
Peters, Jay
Brooks, Edward G
Author_xml – sequence: 1
  givenname: Jay
  surname: Peters
  fullname: Peters, Jay
  email: peters@uthscsa.edu
  organization: Department of Medicine, University of Texas Health Science Center at San Antonio, TX. Electronic address: peters@uthscsa.edu
– sequence: 2
  givenname: Harjinder
  surname: Singh
  fullname: Singh, Harjinder
  organization: Department of Medicine, University of Texas Health Science Center at San Antonio, TX
– sequence: 3
  givenname: Edward G
  surname: Brooks
  fullname: Brooks, Edward G
  organization: Department of Pediatrics, University of Texas Health Science Center at San Antonio, TX
– sequence: 4
  givenname: Joseph
  surname: Diaz
  fullname: Diaz, Joseph
  organization: Asthma and Allergy Associates of South Texas, San Antonio, TX
– sequence: 5
  givenname: Thirumalai R
  surname: Kannan
  fullname: Kannan, Thirumalai R
  organization: Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, TX
– sequence: 6
  givenname: Jacqueline J
  surname: Coalson
  fullname: Coalson, Jacqueline J
  organization: Department of Pathology, University of Texas Health Science Center at San Antonio, TX
– sequence: 7
  givenname: Janet G
  surname: Baseman
  fullname: Baseman, Janet G
  organization: Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, TX
– sequence: 8
  givenname: Marianna
  surname: Cagle
  fullname: Cagle, Marianna
  organization: Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, TX
– sequence: 9
  givenname: Joel B
  surname: Baseman
  fullname: Baseman, Joel B
  organization: Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, TX; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21622549$$D View this record in MEDLINE/PubMed
BookMark eNo1kElLBDEYRIMozqJHr5I_kDFLd2dylMENFD3oefgmixOZJG2SBttf77idigfFg6oZOowpWoTOGF0wIZcXemtLXTBGKOfsAE2ZEoyIthETNCvljVLKmOqO0YSzjvO2UVP0-WRz8aXaqC1ODusUwhB9HQno98Fna3C2pfcZasojNvvqngsuYzQ5BYtr-vCR9DmZQfv4ih9GnfodlAC4j3YIKXqw2Me9xmXQPxYodRvgBB052BV7-pdz9HJ99by6JfePN3ery3uiO9ZWYuhGWGeMNBvjpLOKAjVUaCW1lC3rhJO8a74XKdBgFG2ZE0vOdQN0Ca3ic3T-6-2HTbBm3WcfII_r_xP4F_bkYzo
CitedBy_id crossref_primary_10_2174_1573396320666230912103056
crossref_primary_10_1073_pnas_1420308112
crossref_primary_10_1002_ppul_26907
crossref_primary_10_4103_ijmr_IJMR_1582_16
crossref_primary_10_1111_mmi_12680
crossref_primary_10_1080_03007995_2018_1505352
crossref_primary_10_1128_mBio_02186_14
crossref_primary_10_1097_INF_0000000000000171
crossref_primary_10_1016_j_rmed_2018_11_016
crossref_primary_10_1371_journal_pone_0102613
crossref_primary_10_1016_j_anai_2017_05_022
crossref_primary_10_1016_j_jaci_2015_09_032
crossref_primary_10_1016_j_anai_2013_01_022
crossref_primary_10_3389_fcimb_2022_882855
crossref_primary_10_1093_infdis_jir557
crossref_primary_10_1378_chest_11_2364
crossref_primary_10_1128_CMR_00114_16
crossref_primary_10_1111_1348_0421_12378
crossref_primary_10_1016_j_iac_2016_03_010
crossref_primary_10_2147_JAA_S313480
crossref_primary_10_3389_fmicb_2021_766591
crossref_primary_10_1111_cmi_13032
crossref_primary_10_1378_chest_11_2909
crossref_primary_10_1371_journal_pone_0062706
crossref_primary_10_1016_j_micpath_2024_106865
crossref_primary_10_1371_journal_pone_0035945
crossref_primary_10_1016_j_jfma_2020_08_018
crossref_primary_10_1128_IAI_00548_17
crossref_primary_10_1093_cid_cir769
crossref_primary_10_1165_rcmb_2011_0135OC
crossref_primary_10_1111_j_1365_2222_2011_03944_x
crossref_primary_10_1016_j_jaci_2018_07_021
crossref_primary_10_1128_mBio_01497_14
crossref_primary_10_3389_fcimb_2025_1496829
crossref_primary_10_1038_s41598_021_90948_3
crossref_primary_10_1128_mBio_01663_17
crossref_primary_10_1128_spectrum_01588_21
crossref_primary_10_1016_j_ijmm_2018_04_003
crossref_primary_10_1007_s11882_013_0390_8
crossref_primary_10_1165_rcmb_2017_0006OC
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1378/chest.11-0221
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1931-3543
ExternalDocumentID 21622549
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: PHS HHS
  grantid: U19A1070412-01
– fundername: NIAID NIH HHS
  grantid: U19 AI070412
GroupedDBID ---
.1-
.55
.FO
.GJ
.XZ
08P
0R~
18M
1P~
29B
2WC
354
36B
3O-
457
53G
5GY
5RE
5RS
6J9
6PF
7RV
7X7
88E
8AO
8C1
8F7
8FI
8FJ
AAEDT
AAEDW
AAKAS
AAKUH
AALRI
AAWTL
AAXUO
AAYOK
ABDBF
ABDQB
ABJNI
ABLJU
ABMAC
ABOCM
ABUWG
ACBMB
ACGFO
ACGFS
ACGUR
ACUHS
ADBBV
ADVLN
ADZCM
AENEX
AEVXI
AFCTW
AFETI
AFFNX
AFJKZ
AFKRA
AFRHN
AFTJW
AGHFR
AHMBA
AI.
AITUG
AJUYK
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AZQEC
B0M
BCGUY
BENPR
BKEYQ
BKNYI
BPHCQ
BVXVI
C1A
C45
CCPQU
CGR
CS3
CUY
CVF
DU5
EAP
EAS
EBC
EBD
EBS
ECM
EHN
EIF
EJD
EMK
ENC
EPT
ESX
EX3
F5P
FDB
FYUFA
GD~
H13
HMCUK
HX~
HZ~
IH2
INR
J5H
K9-
L7B
LXL
LXN
M0R
M1P
M5~
MJL
MV1
N4W
N9A
NAPCQ
NEJ
NPM
O6.
O9-
OB3
OBH
ODZKP
OFXIZ
OGROG
OHH
OI-
OU.
OVD
OVIDX
P2P
PCD
PHGZT
PQQKQ
PROAC
PSQYO
Q~Q
RIG
ROL
SJN
SSZ
TCP
TEORI
TR2
TUS
TWZ
UKHRP
VH1
W8F
WH7
WOQ
WOW
X7M
XOL
YFH
YHG
YOC
YQJ
Z5R
ZGI
ZRQ
ZXP
ZY1
~8M
ID FETCH-LOGICAL-c615t-d0b3efdd7dbdf7fe90a0d03c97c775163f726421629acad9051f3822c4a08a592
IngestDate Thu Apr 03 07:06:20 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c615t-d0b3efdd7dbdf7fe90a0d03c97c775163f726421629acad9051f3822c4a08a592
OpenAccessLink http://journal.chestnet.org/article/S0012369211604145/pdf
PMID 21622549
ParticipantIDs pubmed_primary_21622549
PublicationCentury 2000
PublicationDate 2011-08-01
PublicationDateYYYYMMDD 2011-08-01
PublicationDate_xml – month: 08
  year: 2011
  text: 2011-08-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Chest
PublicationTitleAlternate Chest
PublicationYear 2011
References 22315126 - Chest. 2012 Feb;141(2):569-70; author reply 570
References_xml – reference: 22315126 - Chest. 2012 Feb;141(2):569-70; author reply 570
SSID ssj0001196
Score 2.2530491
Snippet The role of Mycoplasma pneumoniae (Mp) in the initiation and persistence of asthma remains elusive. Mp community-acquired respiratory distress syndrome toxin...
SourceID pubmed
SourceType Index Database
StartPage 401
SubjectTerms Adhesins, Bacterial - blood
Adult
Asthma - complications
Asthma - microbiology
Bacterial Proteins - metabolism
Bacterial Toxins - metabolism
Community-Acquired Infections
Female
Humans
Male
Middle Aged
Mycoplasma pneumoniae - metabolism
Nasal Lavage Fluid
Pneumonia, Mycoplasma - complications
Pneumonia, Mycoplasma - microbiology
Respiratory Distress Syndrome - complications
Respiratory Distress Syndrome - microbiology
Sputum - microbiology
Title Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma
URI https://www.ncbi.nlm.nih.gov/pubmed/21622549
Volume 140
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa2ICEuFe8CBfnArXJJYmddH0sBrSqVC63UW-X4oQbUbFRSqbv_gH_dGdvZpFsQj0u0ijfZbObzeGY88w0h73KtrOWCM5EbzWCFtjCllGQq88YWWPzoQ5bvl-nsRByelqeTyc9R1tJVV-2a5S_rSv5HqnAO5IpVsv8g2dVN4QR8BvnCESQMx7-SMaavo5hwcsb0cCz26BZMG0zwdViZMuyk2zoVhvQsBWB3XtcNawPpK4YMjhZm3oI5faF32sZdwf-otYsVL_4yNOZZ7Ogf3XnS5T3BwXm_RRU7dKWua4dDes5XuHkI38z05TfkZ1xlBH8Aw_17rIgI3aOHVl8fa70cbVGMghMx2pqCEy4qVMVzxstIxbTSuJGhKUGrGOlPES--o9e5xFqF0EJsF3-lKG59D8TSXgQhF_m0QJ_3z6NrNNv90AbZAIcDO6hi2Cct6TnoqUTQCk_y_tZzBDrpeO2aaxJMlONHZDP5FnQ_AuUxmbjmCXlwlLInnpLlCC907uldvNARXmiPF9rjha7hhQ54oQNeaN3QAS804uUZOfn86fhgxlLvDWbAxu2YzSruvLXSVtZL71SmM5txo6SRsgQj3ssCa6SnhdJGW2R58xyMTSN0tqdLVTwn95p547YIRaeZK5HtGe0EjCvvtRBlVUprYUFxL8mL-NbO2kiwcta_z1e_HXlNHg5w2yb3Pcxo9wbMw656G0R3A4vgbak
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Persistence+of+community-acquired+respiratory+distress+syndrome+toxin-producing+Mycoplasma+pneumoniae+in+refractory+asthma&rft.jtitle=Chest&rft.au=Peters%2C+Jay&rft.au=Singh%2C+Harjinder&rft.au=Brooks%2C+Edward+G&rft.au=Diaz%2C+Joseph&rft.date=2011-08-01&rft.eissn=1931-3543&rft.volume=140&rft.issue=2&rft.spage=401&rft_id=info:doi/10.1378%2Fchest.11-0221&rft_id=info%3Apmid%2F21622549&rft_id=info%3Apmid%2F21622549&rft.externalDocID=21622549